DRI Cocaine Metabolite Assay— 510(k) K211973

Substantially Equivalent

Microgenics Corporation

FDA 510(k) clearance K211973 for DRI Cocaine Metabolite Assay, Substantially Equivalent on 2021-09-24. Applicant: Microgenics Corporation.

Clearance details

Applicant
Microgenics Corporation
Product code
Code DIO
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Fremont, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.